4D Molecular Therapeutics CEO David Kirn's 2022 pay falls 37% to $3.3M
4D Molecular Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 12, 2023
4D Molecular Therapeutics reported fiscal year 2022 executive compensation information on April 12, 2023.
In 2022, three executives at 4D Molecular Therapeutics received on average a compensation package of $2.6M, a 20% decrease compared to previous year.
Average pay of disclosed executives at 4D Molecular Therapeutics
David Kirn, Chief Executive Officer, received $3.3M in total, which decreased by 37% compared to 2021. 72% of Kirn's compensation, or $2.4M, was in option awards. Kirn also received $322K in non-equity incentive plan, $586K in salary, as well as $14K in other compensation.
Fariborz Kamal, Chief Operating Officer, received a compensation package of $2.4M. 72% of the compensation package, or $1.7M, was in option awards.
August J. Moretti, Chief Financial Officer, earned $2.2M in 2022, a 18% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 12, 2023.